| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00262-006-0230-Y |
| P698 | PubMed publication ID | 16988823 |
| P2093 | author name string | André Ménez | |
| Pierre van der Bruggen | |||
| Bernard Maillère | |||
| Dominique Charron | |||
| Christine Almunia | |||
| Bernard Lethé | |||
| Xiao-Fei Wang | |||
| Florence A Castelli | |||
| Sandra Pouvelle-Moratille | |||
| Marc Busson | |||
| William M Cohen | |||
| Gaetan Munier | |||
| Hassan M Zarour | |||
| P2860 | cites work | Scanning the HIV genome for CD4+ T cell epitopes restricted to HLA-DP4, the most prevalent HLA class II molecule | Q40290676 |
| Monitoring of anti-vaccine CD4 T cell frequencies in melanoma patients vaccinated with a MAGE-3 protein. | Q40460679 | ||
| Functional analysis of tumor-specific Th cell responses detected in melanoma patients after dendritic cell-based immunotherapy | Q40602057 | ||
| HLA-DP4, the most frequent HLA II molecule, defines a new supertype of peptide-binding specificity | Q40684761 | ||
| A tumor-infiltrating lymphocyte from a melanoma metastasis with decreased expression of melanoma differentiation antigens recognizes MAGE-12. | Q40831581 | ||
| A MAGE-3 peptide presented by HLA-DR1 to CD4+ T cells that were isolated from a melanoma patient vaccinated with a MAGE-3 protein | Q42601954 | ||
| Vaccine-induced CD4+ T cell responses to MAGE-3 protein in lung cancer patients. | Q51024694 | ||
| Rationally engineered therapeutic proteins with reduced immunogenicity. | Q51532528 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 807-818 | |
| P577 | publication date | 2006-09-20 | |
| P1433 | published in | Cancer Immunology, Immunotherapy | Q5031409 |
| P1476 | title | Selective identification of HLA-DP4 binding T cell epitopes encoded by the MAGE-A gene family. | |
| P478 | volume | 56 |
| Q35785418 | Automated benchmarking of peptide-MHC class I binding predictions |
| Q38912232 | Cancer testis antigen and immunotherapy |
| Q28731516 | Development of a humanized HLA-A2.1/DP4 transgenic mouse model and the use of this model to map HLA-DP4-restricted epitopes of HBV envelope protein |
| Q36871818 | Dissociation between epitope hierarchy and immunoprevalence in CD8 responses to vaccinia virus western reserve |
| Q33939709 | Evolutionary history of the cancer immunity antigen MAGE gene family. |
| Q36960744 | GSK's antigen-specific cancer immunotherapy programme: pilot results leading to Phase III clinical development |
| Q37773275 | MAGE A3 antigen-specific cancer immunotherapeutic |
| Q39171951 | The signal peptide of the tumor-shared antigen midkine hosts CD4+ T cell epitopes |
Search more.